Sherrill House has emerged as a leading provider of skilled nursing care for individuals living with Lewy body dementia. Treatment is tailored to each resident, with an emphasis on maximizing daily function and enhancing quality of life. Our interdisciplinary staff has extensive experience in caring for residents with Lewy body disease, and receives ongoing support and education.
Lewy body dementia (LBD) is one of the most common types of progressive brain diseases, and the second leading cause, after Alzheimer’s disease, of degenerative dementia in older adults. LBD occurs when Lewy bodies, abnormal round structures of alpha-synuclein protein, develop in the areas of the brain that control thinking and movement. Symptoms include progressive cognitive decline and problems with motor function as well as fluctuations in attention and visual hallucinations.
The importance of early diagnosis:
The symptoms of LBD can mimic those of both Alzheimer’s disease and Parkinson’s disease. LBD can, in fact, occur in combination with these diseases, making an accurate diagnosis difficult. Many medications used to treat Alzheimer’s and Parkinson’s symptoms can have an adverse effect on people with LBD, so an accurate diagnosis, ideally by a diagnostic team with experience in identifying LBD, is critical.
Education and support for families and friends:
Sherrill House hosts a monthly LBD caregiver support group, the only one of its kind in Boston, in conjunction with the Lewy Body Dementia Association. For more information contact Melissa Muccioli at firstname.lastname@example.org.
Sherrill House sponsors a Lewy body dementia educational symposium each fall, which is open to the public. Past speakers have included prominent neurologists and physicians including John Growdon, M.D., Stephen Gomperts, M.D., Ph.D., and Thomas Graboys, M.D.